Beginning in 2008, the FDA began notifying clinicians of the potential of antiepileptic drugs to increase suicide risk and earlier in 2009 issued a public health advisory notifying the public of this increased risk. Also, the FDA is mandating that manufacturers of antiepileptic drugs change the labeling of their meds, adding this risk to the Warnings section of the drug insert.
